α-Glucosidase-IN-21
Product Specifications
UNSPSC Description
α-Glucosidase-IN-21 (Compound 2B) is a potent, orally active α-glucosidase inhibitor with an IC50 of 2.62 μM. α-Glucosidase-IN-21 shows anti-diabetic activity[1].
Target Antigen
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/α-glucosidase-in-21.html
Solubility
10 mM in DMSO
Smiles
CC1=CC=C(C2=NC3=CC=CC=C3SC(C4=CC=C(OC)C(OC)=C4)C2)C=C1
Molecular Weight
389.51
References & Citations
[1]Mehmood R, et al. Synthesis of Novel 2, 3-Dihydro-1, 5-Benzothiazepines as α-Glucosidase Inhibitors: In Vitro, In Vivo, Kinetic, SAR, Molecular Docking, and QSAR Studies. ACS Omega, 2022 Aug 17.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-151145/α-Glucosidase-IN-21-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-151145/
Clinical Information
No Development Reported
CAS Number
321686-01-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1416230-01 0.02 mg (E-Coli)
Recombinant Human Kinesin-like protein KIF15 (KIF15) , partial
Ask
View Details MBS1416230-02 0.1 mg (E-Coli)
Recombinant Human Kinesin-like protein KIF15 (KIF15) , partial
Ask
View Details MBS1416230-03 0.02 mg (Yeast)
Recombinant Human Kinesin-like protein KIF15 (KIF15) , partial
Ask
View Details MBS1416230-04 0.1 mg (Yeast)
Recombinant Human Kinesin-like protein KIF15 (KIF15) , partial
Ask
View Details 
MBS1416230-05 0.02 mg (Baculovirus)
Recombinant Human Kinesin-like protein KIF15 (KIF15) , partial
Ask
View Details